Abstract
Several nuclear imaging techniques can be used to diagnose infectious and inflammatory processes. F-18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a useful diagnostic technique to detect inflammation and infection quickly and accurately. We report the case of a patient with end-stage renal disease (ESRD) and recurrent bacterial infections where FDG PET/CT was used to identify the source of infection as sternal osteomyelitis and rule out suspected infection of the aortic valve prosthesis.
Keywords: site of infection, pet scans, ct (computed tomography) imaging, nuclear medicine imaging, aortic valve
Introduction
Infection and inflammation can be detected with various nuclear medicine imaging techniques. For example, imaging with technetium 99m (99mTc) methylene diphosphonate, gallium 67 (67Ga) citrate, indium 111 (111In)-oxine autologous labeled leukocytes, and 99mTc hexylmethylpropylene amineoxime autologous labeled leukocytes can provide diagnostic information; however, each has limitations [1,2]. F-18-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is a useful method to detect inflammation and infection quickly and with high sensitivity [3].
FDG PET/CT measures metabolic tissue activity. The uptake of FDG is increased in tissues with increased glucose consumption, such as sites of increased inflammation [4-6]. Inflammatory cells, such as neutrophils and macrophages, have increased glucose transporters [4,6]. Thus, sites of infection can be visualized using FDG PET/CT.
Previous research has found that FDG PET/CT is useful in identifying fevers of undetermined origin (FUO) [7], focal infection [8], and osteomyelitis [9]. Here, we present the case of a patient with suspected infection of a prosthetic aortic valve, and the usefulness of FDG PET/CT in ruling out infection of the valve.
Case presentation
A man with a past medical history of end-stage renal disease (ESRD) on hemodialysis, aortic dissection, bioprosthetic valve, and recurrent bacteremia was admitted as a transfer for line exchange after he was found to have methicillin-resistant Staphylococcus aureus (MRSA) bacteremia and symptoms of fevers, night sweats, and chills. The patient received vancomycin and subsequent cultures were negative for MRSA, however, repeat blood cultures grew Proteus mirabilis. Multiple sources of recurrent infection were possible, including his permanent dialysis catheter, bioprosthetic aortic valve, or aortic root graft, but the most likely source was thought to be the dialysis catheter. Interventional radiology performed removal of the permanent catheter. Blood cultures and catheter tip cultures were drawn following removal. The catheter tip did not have bacterial growth, however, blood cultures were positive for MRSA and the patient was given appropriate antibiotics.
Given the patient’s history of recurrent infections, the attending team needed to identify the source and discuss its replacement. The attending team discussed whether a gallium scan or tagged WBC scan would be helpful in identifying the source of the infection with the nuclear medicine team. Attending radiologists recommended a PET scan to evaluate prosthesis.
The scan revealed hypermetabolism in the upper sternal body, suspicious for osteomyelitis (Figures 1, 2). The bone in the region of hypermetabolism was abnormal. The sternotomy was unfused and showed no signs of healing. The margins of the upper sternotomy, which is the region of osseous hypermetabolism, were irregular with areas of erosion. More inferiorly, the sternotomy showed callus formation, no erosions, and no hypermetabolism.
Figure 1. F-18-Fluorodeoxyglucose Positron Emission Tomography Scan.
A diagnostic FDG PET scan found moderate to marked hypermetabolism within the sternotomy line with maximum standard uptake value (SUV) 4.6.
FDG PET: F-18-fluorodeoxyglucose positron emission tomography
Figure 2. F-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scan.
FDG PET/CT scan revealed hypermetabolism in the upper sternal body with adjacent soft tissue in the anterior mediastinum, suspicious for osteomyelitis. An additional crescentic collection was found along the right aspect of the ascending aortic arch that did not extend along with the prosthetic valve. The scan includes axial (A), sagittal (B), and coronal (C) views. The red circles denote sites of increased FDG uptake.
FDG PET/CT: F-18-fluorodeoxyglucose positron emission tomography/computed tomography
An additional crescentic collection was found along the right aspect of the ascending aortic arch, however, it did not extend along with the valve. The collection was most likely a hematoma, measuring above fluid attenuation by CT. Whether there was infection superimposed upon the hematoma is unknown, though possible. While the collection abutted the prosthetic valve, there was no other uptake around the valve to suggest infection of the prosthesis. Thus, the source of infection was likely from the sternum and aortic arch and not from the aortic valve prosthesis.
The patient’s antibiotic therapy was extended. A second PET scan confirmed the infection was not from the aortic valve prosthesis. The patient underwent AV fistula creation for permanent dialysis access.
Discussion
A variety of nuclear imaging studies can aid in the diagnosis of infection, particularly in complex cases of recurrent bacteremia, such as the case presented above. MRI is used often in infection imaging but has prolonged acquisition times and may have inconclusive results in certain infectious processes [10,11]. White blood cell imaging is another technique that may be used, but it exhibits a low range of sensitivity in chronic infection, such as chronic osteomyelitis [10]. FDG PET/CT is a particularly useful diagnostic technique to identify the source of infection. FDG PET/CT also shows increased uptake in bone lesions, such as brown tumors. Advantages include short acquisition time, high-resolution, and increased sensitivity in chronic and spinal infection [10].
FDG PET has been shown to have value in the diagnosis of chronic limb osteomyelitis, where it has high rates of specificity and sensitivity [12,13]. For example, the sensitivity and specificity of FDG PET were found to have sensitivity and specificity over 95% in the diagnosis of osteomyelitis [13]. Three-phase bone scintigraphy and labeled white cell scintigraphy have comparatively lower rates of sensitivity and specificity [12].
The infection of a prosthetic aortic valve is associated with high rates of morbidity and mortality [14]. This is partly due to a delay in diagnosing infection and identifying the source [15]. Patients may also present with a wide range of symptoms, delaying accurate diagnosis and treatment [15]. Thus, it is imperative to quickly identify the source of infection to result in improved outcomes. Further, if the infection of a prosthetic aortic valve is suspected, accurate diagnosis is vital, given the high rates of mortality associated with valve replacement [16]. In this setting of a patient with recurrent bacteremia, FDG PET/CT was helpful in ruling out infection of aortic valve prosthesis (and thus avoiding high-risk surgery) and diagnosing osteomyelitis.
Conclusions
FDG PET/CT can be used to identify the source of infection or exclude certain infectious processes with high sensitivity. FDG PET/CT ruled out infection of the aortic valve prosthesis in this patient with recurrent bacteremia. Given its increasing availability, as well as rapidness and relatively lower cost compared to labeled WBC scan, FDG PET/CT should be considered in the diagnosis of infectious processes.
The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.
The authors have declared that no competing interests exist.
Human Ethics
Consent was obtained by all participants in this study
References
- 1.The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Signore A, Glaudemans AW. Ann Nucl Med. 2011;25:681–700. doi: 10.1007/s12149-011-0521-z. [DOI] [PubMed] [Google Scholar]
- 2.Labeled leukocyte imaging: current status and future directions. Palestro C, Love C, Bhargava K. https://search.proquest.com/docview/214574862?accountid=6724. Q J Nucl Med Mol Imaging. 2009;53:105–123. [PubMed] [Google Scholar]
- 3.Nuclear medicine and the infected joint replacement. Love C, Marwin SE, Palestro CJ. Sem Nucl Med. 2009;39:66–78. doi: 10.1053/j.semnuclmed.2008.08.007. [DOI] [PubMed] [Google Scholar]
- 4.Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. http://jnm.snmjournals.org/content/33/11/1972.short. J Nucl Med. 1992;33:1972–1980. [PubMed] [Google Scholar]
- 5.18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Zhuang H, Alavi A. Semin Nucl Med. 2002;32:47–59. doi: 10.1053/snuc.2002.29278. [DOI] [PubMed] [Google Scholar]
- 6.FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. Mochizuki T, Tsukamoto E, Kuge Y, et al. http://jnm.snmjournals.org/content/42/10/1551.short. J Nucl Med. 2001;42:1551–1555. [PubMed] [Google Scholar]
- 7.Clinical value of [18F] fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Blockmans D, Knockaert D, Maes A, De Caestecker J, Stroobants S, Bobbaers H, Mortelmans L. Arch Clin Infect Dis. 2001;32:191–196. doi: 10.1086/318480. [DOI] [PubMed] [Google Scholar]
- 8.Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Eur J Nucl Med Mol Imaging. 2004;31:29–37. doi: 10.1007/s00259-003-1338-3. [DOI] [PubMed] [Google Scholar]
- 9.Diagnostic value of 18 F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KD. Eur J Nucl Med Mol Imaging. 2007;34:704–714. doi: 10.1007/s00259-006-0290-4. [DOI] [PubMed] [Google Scholar]
- 10.FDG PET/CT in infection and inflammation—current and emerging clinical applications. Vaidyanathan S, Patel C, Scarsbrook A, Chowdhury F. Clin Radiol. 2015;70:787–800. doi: 10.1016/j.crad.2015.03.010. [DOI] [PubMed] [Google Scholar]
- 11.Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. El-Haddad G, Zhuang H, Gupta N, Alavi A. Semin Nucl Med. 2004;34:313–329. doi: 10.1053/j.semnuclmed.2004.06.006. [DOI] [PubMed] [Google Scholar]
- 12.The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. Termaat M, Raijmakers P, Scholten H, Bakker F, Patka P, Haarman H. J Bone Joint Surg Am. 2005;87:2464–2471. doi: 10.2106/JBJS.D.02691. [DOI] [PubMed] [Google Scholar]
- 13.PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. van der Bruggen W, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. Semin Nucl Med. 2010;40:3–15. doi: 10.1053/j.semnuclmed.2009.08.005. [DOI] [PubMed] [Google Scholar]
- 14.Aortic valve infection: risk factors for death and recurrent endocarditis after aortic valve replacement. McGiffin DC, Galbraith AJ, McLachlan GJ, et al. J Thorac Cardiovasc Surg. 1992;104:511–520. [PubMed] [Google Scholar]
- 15.Management of infective endocarditis: challenges and perspectives. Thuny F, Grisoli D, Collart F, Habib G, Raoult D. Lancet. 2012;379:965–975. doi: 10.1016/S0140-6736(11)60755-1. [DOI] [PubMed] [Google Scholar]
- 16.Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes. Chu VH, Crosslin DR, Friedman JY, et al. Am J Med. 2005;118:1416. doi: 10.1016/j.amjmed.2005.06.011. [DOI] [PubMed] [Google Scholar]


